Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

Original languageEnglish
Pages (from-to)215
Number of pages1
JournalIndian Journal of Dermatology
Volume60
Issue number2
DOIs
Publication statusPublished - 1 Apr 2015

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'Scleromyxedema, a therapeutic dilemma'. Together they form a unique fingerprint.

  • Cite this

    Salas-Alanis, J. C., Martinez-Jaramillo, B., Gomez-Flores, M., & Ocampo-Candiani, J. (2015). Scleromyxedema, a therapeutic dilemma. Indian Journal of Dermatology, 60(2), 215. https://doi.org/10.4103/0019-5154.152600